We report the first patient experiences with the CardioMEMS device in the Erasmus MC Thorax Center in the Netherlands. In line with clinical trial evidence, the device is applicable in patients with chronic heart failure in functional New York Heart Association class III with at least 1 admission for heart failure in the past 12 months. CardioMEMS has been shown to be safe and reliable, and effective in reducing the number of hospitalisations for heart failure by guided therapy based on pulmonary artery pressures.

Additional Metadata
Keywords CardioMEMS, Heart failure, Individualized therapy, Remote monitoring, Telemonotoring
Persistent URL dx.doi.org/10.1007/s12471-017-1054-4, hdl.handle.net/1765/104607
Journal Netherlands Heart Journal
Brugts, J.J, Manintveld, O.C, & van Mieghem, N.M. (2018). Remote monitoring of pulmonary artery pressures with cardiomems in patients with chronic heart failure and nyha class III: First experiences in the Netherlands. Netherlands Heart Journal, 26(2), 55–57. doi:10.1007/s12471-017-1054-4